Cargando…
Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925790/ https://www.ncbi.nlm.nih.gov/pubmed/36781844 http://dx.doi.org/10.1038/s41408-023-00796-9 |
_version_ | 1784888132364140544 |
---|---|
author | Mithraprabhu, Sridurga Reynolds, John Turner, Rose Quach, Hang Horvath, Noemi Kerridge, Ian Kalff, Anna Bergin, Krystal Hocking, Jay Yuen, Flora Khong, Tiffany Durie, Brian M. Spencer, Andrew |
author_facet | Mithraprabhu, Sridurga Reynolds, John Turner, Rose Quach, Hang Horvath, Noemi Kerridge, Ian Kalff, Anna Bergin, Krystal Hocking, Jay Yuen, Flora Khong, Tiffany Durie, Brian M. Spencer, Andrew |
author_sort | Mithraprabhu, Sridurga |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9925790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-99257902023-02-15 Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma Mithraprabhu, Sridurga Reynolds, John Turner, Rose Quach, Hang Horvath, Noemi Kerridge, Ian Kalff, Anna Bergin, Krystal Hocking, Jay Yuen, Flora Khong, Tiffany Durie, Brian M. Spencer, Andrew Blood Cancer J Correspondence Nature Publishing Group UK 2023-02-13 /pmc/articles/PMC9925790/ /pubmed/36781844 http://dx.doi.org/10.1038/s41408-023-00796-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correspondence Mithraprabhu, Sridurga Reynolds, John Turner, Rose Quach, Hang Horvath, Noemi Kerridge, Ian Kalff, Anna Bergin, Krystal Hocking, Jay Yuen, Flora Khong, Tiffany Durie, Brian M. Spencer, Andrew Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma |
title | Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma |
title_full | Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma |
title_fullStr | Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma |
title_full_unstemmed | Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma |
title_short | Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma |
title_sort | circulating tumour dna analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925790/ https://www.ncbi.nlm.nih.gov/pubmed/36781844 http://dx.doi.org/10.1038/s41408-023-00796-9 |
work_keys_str_mv | AT mithraprabhusridurga circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma AT reynoldsjohn circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma AT turnerrose circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma AT quachhang circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma AT horvathnoemi circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma AT kerridgeian circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma AT kalffanna circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma AT berginkrystal circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma AT hockingjay circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma AT yuenflora circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma AT khongtiffany circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma AT duriebrianm circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma AT spencerandrew circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma |